The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.
 
John H. Sampson
Stock and Other Ownership Interests - Annias Immunotherapeutics; ISTARI
Consulting or Advisory Role - Annias Immunotherapeutics; Insera Health; Medicenna
Patents, Royalties, Other Intellectual Property - Annias Immunotherapeutics - Equity, Licensed IP; Istari Oncology - Equity, Licensed IP; Neuronium - Equity, Optioned IP
 
Kristen A Batich
Patents, Royalties, Other Intellectual Property - Tetanus toxoid and CCL3 improve DC vaccines
 
Duane Anthony Mitchell
Stock and Other Ownership Interests - iOncologi
Consulting or Advisory Role - Bristol-Myers Squibb; Oncorus; RM Global; Tocagen
Research Funding - Immunomic Therapeutics
Patents, Royalties, Other Intellectual Property - IP, licensed to Annias, Inc.; IP, licensed to Celldex, Inc.; IP, licensed to Immunomix, Inc.; IP, licensed to iOncologi, Inc.
 
James Emmett Herndon
No Relationships to Disclose
 
Gloria Broadwater
No Relationships to Disclose
 
Patrick Healy
No Relationships to Disclose
 
Luis Sanchez-Perez
No Relationships to Disclose
 
Smita Nair
Patents, Royalties, Other Intellectual Property - Sequential treatment of chemotherapy with a chimeric poliovirus construct
 
Kendra Congdon
No Relationships to Disclose
 
Pamela Norberg
No Relationships to Disclose
 
Kent J. Weinhold
No Relationships to Disclose
 
Gerald E. Archer
No Relationships to Disclose
 
Elizabeth A. Reap
No Relationships to Disclose
 
Weihua Xie
No Relationships to Disclose
 
Roger E. McLendon
Patents, Royalties, Other Intellectual Property - Oligodendroglioma drive genes
 
David A. Reardon
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Omniox
 
James J. Vredenburgh
No Relationships to Disclose
 
Henry S. Friedman
Stock and Other Ownership Interests - Cancer Expert Now; Diverse Biotech; ISTARI Oncology
Consulting or Advisory Role - Cancer Expert Now; Diverse Biotech; ISTARI Oncology
Patents, Royalties, Other Intellectual Property - Letters of Patent for Oncolytic Poliovirus for Human Tumors
 
Darell Bigner
Stock and Other Ownership Interests - ISTARI Oncology
Consulting or Advisory Role - ISTARI Oncology; Vimana
Patents, Royalties, Other Intellectual Property - Detection of CD155 the Poliovirus Receptor; Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma; Oncolytic Poliovirus for Human Tumors; Sequential treatment of chemotherapy a chimeric poliovirus constructand
 
Allan H. Friedman
Stock and Other Ownership Interests - ISTARI Oncology
Patents, Royalties, Other Intellectual Property - Sequential treatment with chimeric poliovirus construct